PMC:7556165 / 15-353
Annnotations
LitCovid-sample-MedDRA
{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":63,"end":92},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T2","span":{"begin":116,"end":119},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T3","span":{"begin":187,"end":190},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10050289"},{"id":"A2","pred":"meddra_id","subj":"T2","obj":"http://purl.bioontology.org/ontology/MEDDRA/10050289"},{"id":"A3","pred":"meddra_id","subj":"T3","obj":"http://purl.bioontology.org/ontology/MEDDRA/10050289"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T1","span":{"begin":63,"end":74},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-PD-NCBITaxon
{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T1","span":{"begin":4,"end":14},"obj":"Species"},{"id":"T2","span":{"begin":4,"end":8},"obj":"Species"}],"attributes":[{"id":"A1","pred":"ncbi_taxonomy_id","subj":"T1","obj":"NCBItxid:2697049"},{"id":"A2","pred":"ncbi_taxonomy_id","subj":"T2","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T2","span":{"begin":16,"end":52},"obj":"Sentence"},{"id":"T3","span":{"begin":54,"end":62},"obj":"Sentence"},{"id":"T4","span":{"begin":63,"end":191},"obj":"Sentence"},{"id":"T5","span":{"begin":192,"end":280},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-PD-UBERON
{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T1","span":{"begin":262,"end":266},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"3","span":{"begin":4,"end":14},"obj":"Species"},{"id":"46","span":{"begin":63,"end":94},"obj":"Gene"},{"id":"47","span":{"begin":96,"end":100},"obj":"Gene"},{"id":"48","span":{"begin":116,"end":119},"obj":"Gene"},{"id":"49","span":{"begin":187,"end":190},"obj":"Gene"},{"id":"50","span":{"begin":192,"end":196},"obj":"Gene"},{"id":"51","span":{"begin":281,"end":285},"obj":"Gene"},{"id":"68","span":{"begin":332,"end":336},"obj":"Gene"},{"id":"77","span":{"begin":262,"end":279},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"pubann:denotes","subj":"50","obj":"Gene:59272"},{"id":"A77","pred":"pubann:denotes","subj":"77","obj":"MESH:D011014"},{"id":"A3","pred":"pubann:denotes","subj":"3","obj":"Tax:2697049"},{"id":"A51","pred":"pubann:denotes","subj":"51","obj":"Gene:59272"},{"id":"A46","pred":"pubann:denotes","subj":"46","obj":"Gene:59272"},{"id":"A47","pred":"pubann:denotes","subj":"47","obj":"Gene:59272"},{"id":"A49","pred":"pubann:denotes","subj":"49","obj":"Gene:1636"},{"id":"A68","pred":"pubann:denotes","subj":"68","obj":"Gene:159371"},{"id":"A48","pred":"pubann:denotes","subj":"48","obj":"Gene:1636"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T2","span":{"begin":63,"end":94},"obj":"Protein"},{"id":"T17","span":{"begin":96,"end":100},"obj":"Protein"},{"id":"T18","span":{"begin":116,"end":119},"obj":"Protein"},{"id":"T43","span":{"begin":187,"end":190},"obj":"Protein"},{"id":"T68","span":{"begin":192,"end":196},"obj":"Protein"},{"id":"T69","span":{"begin":281,"end":285},"obj":"Protein"}],"attributes":[{"id":"A2","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A3","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q9NRA7"},{"id":"A4","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q9BYF1"},{"id":"A5","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q99N71"},{"id":"A6","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q99N70"},{"id":"A7","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q8R0I0"},{"id":"A8","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q86WT0"},{"id":"A9","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q6UWP0"},{"id":"A10","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q5RFN1"},{"id":"A11","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q5EGZ1"},{"id":"A12","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q58DD0"},{"id":"A13","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q56NL1"},{"id":"A14","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q56H28"},{"id":"A15","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q2PGE2"},{"id":"A16","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/C7ECU1"},{"id":"A17","pred":"uniprot_id","subj":"T17","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A18","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q9GLN7"},{"id":"A19","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q9GLN6"},{"id":"A20","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q9EQM9"},{"id":"A21","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q8CFN1"},{"id":"A22","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q7TMC6"},{"id":"A23","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q7M4L4"},{"id":"A24","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q6GTS2"},{"id":"A25","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q59GY8"},{"id":"A26","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q53YX9"},{"id":"A27","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q50JE5"},{"id":"A28","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q10751"},{"id":"A29","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q0GA41"},{"id":"A30","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P47820"},{"id":"A31","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P22968"},{"id":"A32","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P22967"},{"id":"A33","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P22966"},{"id":"A34","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P12822"},{"id":"A35","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P12821"},{"id":"A36","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P12820"},{"id":"A37","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P09470"},{"id":"A38","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/O02852"},{"id":"A39","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/E7EU16"},{"id":"A40","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/B4DXI3"},{"id":"A41","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/B0LPF0"},{"id":"A42","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q9VJV3"},{"id":"A43","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q9GLN7"},{"id":"A44","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q9GLN6"},{"id":"A45","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q9EQM9"},{"id":"A46","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q8CFN1"},{"id":"A47","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q7TMC6"},{"id":"A48","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q7M4L4"},{"id":"A49","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q6GTS2"},{"id":"A50","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q59GY8"},{"id":"A51","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q53YX9"},{"id":"A52","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q50JE5"},{"id":"A53","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q10751"},{"id":"A54","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q0GA41"},{"id":"A55","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P47820"},{"id":"A56","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P22968"},{"id":"A57","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P22967"},{"id":"A58","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P22966"},{"id":"A59","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P12822"},{"id":"A60","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P12821"},{"id":"A61","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P12820"},{"id":"A62","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P09470"},{"id":"A63","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/O02852"},{"id":"A64","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/E7EU16"},{"id":"A65","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/B4DXI3"},{"id":"A66","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/B0LPF0"},{"id":"A67","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q9VJV3"},{"id":"A68","pred":"uniprot_id","subj":"T68","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A69","pred":"uniprot_id","subj":"T69","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":262,"end":266},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-PD-MONDO
{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T1","span":{"begin":4,"end":14},"obj":"Disease"},{"id":"T2","span":{"begin":4,"end":8},"obj":"Disease"},{"id":"T3","span":{"begin":267,"end":279},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-PD-MAT
{"project":"LitCovid-sample-PD-MAT","denotations":[{"id":"T1","span":{"begin":262,"end":266},"obj":"http://purl.obolibrary.org/obo/MAT_0000135"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-PD-GO-BP-0
{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T1","span":{"begin":267,"end":279},"obj":"http://purl.obolibrary.org/obo/GO_0006954"},{"id":"T2","span":{"begin":312,"end":327},"obj":"http://purl.obolibrary.org/obo/GO_0006351"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sample-GO-BP
{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T1","span":{"begin":267,"end":279},"obj":"http://purl.obolibrary.org/obo/GO_0006954"},{"id":"T2","span":{"begin":312,"end":327},"obj":"http://purl.obolibrary.org/obo/GO_0006351"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":4,"end":14},"obj":"Species"},{"id":"46","span":{"begin":63,"end":94},"obj":"Gene"},{"id":"47","span":{"begin":96,"end":100},"obj":"Gene"},{"id":"48","span":{"begin":116,"end":119},"obj":"Gene"},{"id":"49","span":{"begin":187,"end":190},"obj":"Gene"},{"id":"50","span":{"begin":192,"end":196},"obj":"Gene"},{"id":"51","span":{"begin":281,"end":285},"obj":"Gene"},{"id":"68","span":{"begin":332,"end":336},"obj":"Gene"},{"id":"77","span":{"begin":262,"end":279},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Tax:2697049"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"Gene:59272"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Gene:59272"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Gene:1636"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"Gene:1636"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Gene:59272"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Gene:59272"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"Gene:159371"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":16,"end":52},"obj":"Sentence"},{"id":"T3","span":{"begin":54,"end":62},"obj":"Sentence"},{"id":"T4","span":{"begin":63,"end":191},"obj":"Sentence"},{"id":"T5","span":{"begin":192,"end":280},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-t"}